Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1988 Nov;149(5):586–591.

Fulminant Hepatic Failure

PMCID: PMC1026537  PMID: 3074559

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Full text

PDF
586

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Kirby R. M., Clements D., Elias E., McMaster P. Fulminant hepatic failure treated by hepatic transplantation. Lancet. 1986 Nov 1;2(8514):1037–1037. doi: 10.1016/s0140-6736(86)92642-5. [DOI] [PubMed] [Google Scholar]
  2. Bernuau J., Rueff B., Benhamou J. P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986 May;6(2):97–106. doi: 10.1055/s-2008-1040593. [DOI] [PubMed] [Google Scholar]
  3. Bihari D. J., Gimson A. E., Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis. 1986 May;6(2):119–128. doi: 10.1055/s-2008-1040595. [DOI] [PubMed] [Google Scholar]
  4. Bismuth H., Samuel D., Gugenheim J., Castaing D., Bernuau J., Rueff B., Benhamou J. P. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med. 1987 Sep;107(3):337–341. doi: 10.7326/0003-4819-107-2-337. [DOI] [PubMed] [Google Scholar]
  5. Bonino F., Smedile A. Delta agent (type D) hepatitis. Semin Liver Dis. 1986 Feb;6(1):28–33. doi: 10.1055/s-2008-1040790. [DOI] [PubMed] [Google Scholar]
  6. Brems J. J., Hiatt J. R., Ramming K. P., Quinones-Baldrich W. J., Busuttil R. W. Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg. 1987 Jul;154(1):137–141. doi: 10.1016/0002-9610(87)90304-7. [DOI] [PubMed] [Google Scholar]
  7. De Cock K. M., Govindarajan S., Valinluck B., Redeker A. G. Hepatitis B virus DNA in fulminant hepatitis B. Ann Intern Med. 1986 Oct;105(4):546–547. doi: 10.7326/0003-4819-105-4-546. [DOI] [PubMed] [Google Scholar]
  8. Demetris A. J., Jaffe R., Sheahan D. G., Burnham J., Spero J., Iwatsuki S., Van Theil D. H., Starzl T. E. Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol. 1986 Oct;125(1):161–172. [PMC free article] [PubMed] [Google Scholar]
  9. Dienstag J. L. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983 Aug;85(2):439–462. [PubMed] [Google Scholar]
  10. Ede R. J., Gimson A. E., Bihari D., Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2(1):43–51. doi: 10.1016/s0168-8278(86)80007-1. [DOI] [PubMed] [Google Scholar]
  11. Ede R. J., Williams R. W. Hepatic encephalopathy and cerebral edema. Semin Liver Dis. 1986 May;6(2):107–118. doi: 10.1055/s-2008-1040594. [DOI] [PubMed] [Google Scholar]
  12. Fraser C. L., Arieff A. I. Hepatic encephalopathy. N Engl J Med. 1985 Oct 3;313(14):865–873. doi: 10.1056/NEJM198510033131406. [DOI] [PubMed] [Google Scholar]
  13. Freeman J. G., Matthewson K., Record C. O. Plasmapheresis in acute liver failure. Int J Artif Organs. 1986 Nov;9(6):433–438. [PubMed] [Google Scholar]
  14. Gimson A. E., Braude S., Mellon P. J., Canalese J., Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982 Sep 25;2(8300):681–683. doi: 10.1016/s0140-6736(82)90711-5. [DOI] [PubMed] [Google Scholar]
  15. Gimson A. E., O'Grady J., Ede R. J., Portmann B., Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology. 1986 Mar-Apr;6(2):288–294. doi: 10.1002/hep.1840060222. [DOI] [PubMed] [Google Scholar]
  16. Gimson A. E., Tedder R. S., White Y. S., Eddleston A. L., Williams R. Serological markers in fulminant hepatitis B. Gut. 1983 Jul;24(7):615–617. doi: 10.1136/gut.24.7.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gimson A. E., White Y. S., Eddleston A. L., Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983 Dec;24(12):1194–1198. doi: 10.1136/gut.24.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Govindarajan S., Chin K. P., Redeker A. G., Peters R. L. Fulminant B viral hepatitis: role of delta agent. Gastroenterology. 1984 Jun;86(6):1417–1420. [PubMed] [Google Scholar]
  19. Horney J. T., Galambos J. T. The liver during and after fulminant hepatitis. Gastroenterology. 1977 Oct;73(4 Pt 1):639–645. [PubMed] [Google Scholar]
  20. Hughes R., Williams R. Clinical experience with charcoal and resin hemoperfusion. Semin Liver Dis. 1986 May;6(2):164–173. doi: 10.1055/s-2008-1040600. [DOI] [PubMed] [Google Scholar]
  21. Iwatsuki S., Esquivel C. O., Gordon R. D., Shaw B. W., Jr, Starzl T. E., Shade R. R., Van Thiel D. H. Liver transplantation for fulminant hepatic failure. Semin Liver Dis. 1985 Nov;5(4):325–328. doi: 10.1055/s-2008-1040628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Iwatsuki S., Popovtzer M. M., Corman J. L., Ishikawa M., Putnam C. W., Katz F. H., Starzl T. E. Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med. 1973 Nov 29;289(22):1155–1159. doi: 10.1056/NEJM197311292892201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jones E. A., Schafer D. F. Hepatic encephalopathy: a neurochemical disorder. Prog Liver Dis. 1986;8:525–540. [PubMed] [Google Scholar]
  24. Macdougall B. R., Bailey R. J., Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977 Mar 19;1(8012):617–619. doi: 10.1016/s0140-6736(77)92055-4. [DOI] [PubMed] [Google Scholar]
  25. O'Grady J. G., Gimson A. E., O'Brien C. J., Pucknell A., Hughes R. D., Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988 May;94(5 Pt 1):1186–1192. doi: 10.1016/0016-5085(88)90011-x. [DOI] [PubMed] [Google Scholar]
  26. O'Grady J. G., Langley P. G., Isola L. M., Aledort L. M., Williams R. Coagulopathy of fulminant hepatic failure. Semin Liver Dis. 1986 May;6(2):159–163. doi: 10.1055/s-2008-1040599. [DOI] [PubMed] [Google Scholar]
  27. O'Grady J. G., Williams R., Calne R. Transplantation in fulminant hepatic failure. Lancet. 1986 Nov 22;2(8517):1227–1227. doi: 10.1016/s0140-6736(86)92247-6. [DOI] [PubMed] [Google Scholar]
  28. Peleman R. R., Gavaler J. S., Van Thiel D. H., Esquivel C., Gordon R., Iwatsuki S., Starzl T. E. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology. 1987 May-Jun;7(3):484–489. doi: 10.1002/hep.1840070312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pond S. M., Olson K. R., Woo O. F., Osterloh J. D., Ward R. E., Kaufman D. A., Moody R. R. Amatoxin poisoning in northern California, 1982-1983. West J Med. 1986 Aug;145(2):204–209. [PMC free article] [PubMed] [Google Scholar]
  30. Rakela J., Kurtz S. B., McCarthy J. T., Krom R. A., Baldus W. P., McGill D. B., Perrault J., Milliner D. S. Postdilution hemofiltration in the management of acute hepatic failure: a pilot study. Mayo Clin Proc. 1988 Feb;63(2):113–118. doi: 10.1016/s0025-6196(12)64943-x. [DOI] [PubMed] [Google Scholar]
  31. Rakela J., Lange S. M., Ludwig J., Baldus W. P. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc. 1985 May;60(5):289–292. doi: 10.1016/s0025-6196(12)60534-5. [DOI] [PubMed] [Google Scholar]
  32. Redeker A. G., Schweitzer I. L., Yamahiro H. S. Letter: Randomization of corticosteroid therapy in fulminant hepatitis. N Engl J Med. 1976 Mar 25;294(13):728–729. doi: 10.1056/NEJM197603252941315. [DOI] [PubMed] [Google Scholar]
  33. Rizzetto M. The delta agent. Hepatology. 1983 Sep-Oct;3(5):729–737. doi: 10.1002/hep.1840030518. [DOI] [PubMed] [Google Scholar]
  34. Tandon B. N., Joshi Y. K., Tandon M. Acute liver failure. Experience with 145 patients. J Clin Gastroenterol. 1986 Dec;8(6):664–668. doi: 10.1097/00004836-198612000-00016. [DOI] [PubMed] [Google Scholar]
  35. Trey C., Davidson C. S. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–298. [PubMed] [Google Scholar]
  36. Tygstrup N., Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis. 1986 May;6(2):129–137. doi: 10.1055/s-2008-1040596. [DOI] [PubMed] [Google Scholar]
  37. Tygstrup N., Ranek L. Fulminant hepatic failure. Clin Gastroenterol. 1981 Jan;10(1):191–208. [PubMed] [Google Scholar]
  38. Weston M. J., Talbot I. C., Horoworth P. J., Mant A. K., Capildeo R., Williams R. Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J. 1976 Nov;38(11):1179–1188. doi: 10.1136/hrt.38.11.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wyke R. J., Canalese J. C., Gimson A. E., Williams R. Bacteraemia in patients with fulminant hepatic failure. Liver. 1982 Mar;2(1):45–52. doi: 10.1111/j.1600-0676.1982.tb00177.x. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES